Importance of sympathetic activation for the expression of Na+-Ca2+ exchanger in end-stage failing human myocardium
Aims In end-stage heart failure, an alteration in the expression of the Na+-Ca2+ exchanger has been reported. Regulation of its expression is largely unknown. We sought to find out whether Na+-Ca2+ exchanger in human heart failure is regulated by sympathetic activation. In addition, since Na+-Ca2+-e...
Saved in:
Published in | European heart journal Vol. 23; no. 14; pp. 1118 - 1124 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Oxford University Press
01.07.2002
|
Subjects | |
Online Access | Get full text |
ISSN | 0195-668X 1522-9645 |
DOI | 10.1053/euhj.2001.3044 |
Cover
Loading…
Abstract | Aims In end-stage heart failure, an alteration in the expression of the Na+-Ca2+ exchanger has been reported. Regulation of its expression is largely unknown. We sought to find out whether Na+-Ca2+ exchanger in human heart failure is regulated by sympathetic activation. In addition, since Na+-Ca2+-exchange is electrogenic, we conjectured whether increased expression of Na+-Ca2+ exchanger is associated with an increased incidence of cardiac arrhythmias. Methods and Results Twenty-three patients suffering from end-stage cardiac failure were examined in the hours preceding cardiac transplantation. Plasma levels of norepinephrine, epinephrine, atrial natriuretic peptide, renin activity, aldosterone, tumour necrosis factor (TNF)-α, and TNF-receptors were measured. All parameters were elevated relative to 21 healthy control subjects. As determined by immunoblots, protein levels of the Na+-Ca2+ exchanger were increased by 56% and protein levels of sarcoplasmic reticulum (SR) Ca2+-ATPase were decreased by 20% in left ventricles of the explanted failing hearts. A significant correlation between protein and neurohumoral levels was exclusively found for the Na+-Ca2+ exchanger with norepinephrine (r=0·64;P =0·01). Recent Holter ECGs revealed that patients with sustained or non-sustained ventricular tachycardia (more than three consecutive beats) had significantly higher Na+-Ca2+ exchanger protein and plasma norepinephrine levels than patients with a maximum of two consecutive beats (Na+-Ca2+ exchanger: 109±10 vs 83±7, n=11 each, P<0·05; norepinephrine: 1359±159 vs 656±88pg.ml−1, n=9 each, P<0·001). Conclusions Sympathetic activation may enhance the expression of Na+-Ca2+ exchanger in end-stage heart failure. The data support the hypothesis that increased Na+-Ca2+-exchange could favour malignant ventricular arrhythmias. Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved. |
---|---|
AbstractList | In end-stage heart failure, an alteration in the expression of the Na+-Ca2+ exchanger has been reported. Regulation of its expression is largely unknown. We sought to find out whether Na+-Ca2+ exchanger in human heart failure is regulated by sympathetic activation. In addition, since Na+-Ca2+-exchange is electrogenic, we conjectured whether increased expression of Na+-Ca2+ exchanger is associated with an increased incidence of cardiac arrhythmias.AIMSIn end-stage heart failure, an alteration in the expression of the Na+-Ca2+ exchanger has been reported. Regulation of its expression is largely unknown. We sought to find out whether Na+-Ca2+ exchanger in human heart failure is regulated by sympathetic activation. In addition, since Na+-Ca2+-exchange is electrogenic, we conjectured whether increased expression of Na+-Ca2+ exchanger is associated with an increased incidence of cardiac arrhythmias.Twenty-three patients suffering from end-stage cardiac failure were examined in the hours preceding cardiac transplantation. Plasma levels of norepinephrine, epinephrine, atrial natriuretic peptide, renin activity, aldosterone, tumour necrosis factor (TNF)-alpha, and TNF-receptors were measured. All parameters were elevated relative to 21 healthy control subjects. As determined by immunoblots, protein levels of the Na+-Ca2+ exchanger were increased by 56% and protein levels of sarcoplasmic reticulum (SR) Ca2+-ATPase were decreased by 20% in left ventricles of the explanted failing hearts. A significant correlation between protein and neurohumoral levels was exclusively found for the Na+-Ca2+ exchanger with norepinephrine (r=0.64; P=0.01). Recent Holter ECGs revealed that patients with sustained or non-sustained ventricular tachycardia (more than three consecutive beats) had significantly higher Na+-Ca2+ exchanger protein and plasma norepinephrine levels than patients with a maximum of two consecutive beats (Na+-Ca2+ exchanger: 109+/-10 vs 83+/-7, n=11 each, P<0.05; norepinephrine: 1359+/-159 vs 656+/-88 pg. ml(-1), n=9 each, P<0.001).METHODS AND RESULTSTwenty-three patients suffering from end-stage cardiac failure were examined in the hours preceding cardiac transplantation. Plasma levels of norepinephrine, epinephrine, atrial natriuretic peptide, renin activity, aldosterone, tumour necrosis factor (TNF)-alpha, and TNF-receptors were measured. All parameters were elevated relative to 21 healthy control subjects. As determined by immunoblots, protein levels of the Na+-Ca2+ exchanger were increased by 56% and protein levels of sarcoplasmic reticulum (SR) Ca2+-ATPase were decreased by 20% in left ventricles of the explanted failing hearts. A significant correlation between protein and neurohumoral levels was exclusively found for the Na+-Ca2+ exchanger with norepinephrine (r=0.64; P=0.01). Recent Holter ECGs revealed that patients with sustained or non-sustained ventricular tachycardia (more than three consecutive beats) had significantly higher Na+-Ca2+ exchanger protein and plasma norepinephrine levels than patients with a maximum of two consecutive beats (Na+-Ca2+ exchanger: 109+/-10 vs 83+/-7, n=11 each, P<0.05; norepinephrine: 1359+/-159 vs 656+/-88 pg. ml(-1), n=9 each, P<0.001).Sympathetic activation may enhance the expression of Na+-Ca2+ exchanger in end-stage heart failure. The data support the hypothesis that increased Na+-Ca2+-exchange could favour malignant ventricular arrhythmias.CONCLUSIONSSympathetic activation may enhance the expression of Na+-Ca2+ exchanger in end-stage heart failure. The data support the hypothesis that increased Na+-Ca2+-exchange could favour malignant ventricular arrhythmias. In end-stage heart failure, an alteration in the expression of the Na+-Ca2+ exchanger has been reported. Regulation of its expression is largely unknown. We sought to find out whether Na+-Ca2+ exchanger in human heart failure is regulated by sympathetic activation. In addition, since Na+-Ca2+-exchange is electrogenic, we conjectured whether increased expression of Na+-Ca2+ exchanger is associated with an increased incidence of cardiac arrhythmias. Twenty-three patients suffering from end-stage cardiac failure were examined in the hours preceding cardiac transplantation. Plasma levels of norepinephrine, epinephrine, atrial natriuretic peptide, renin activity, aldosterone, tumour necrosis factor (TNF)-alpha, and TNF-receptors were measured. All parameters were elevated relative to 21 healthy control subjects. As determined by immunoblots, protein levels of the Na+-Ca2+ exchanger were increased by 56% and protein levels of sarcoplasmic reticulum (SR) Ca2+-ATPase were decreased by 20% in left ventricles of the explanted failing hearts. A significant correlation between protein and neurohumoral levels was exclusively found for the Na+-Ca2+ exchanger with norepinephrine (r=0.64; P=0.01). Recent Holter ECGs revealed that patients with sustained or non-sustained ventricular tachycardia (more than three consecutive beats) had significantly higher Na+-Ca2+ exchanger protein and plasma norepinephrine levels than patients with a maximum of two consecutive beats (Na+-Ca2+ exchanger: 109+/-10 vs 83+/-7, n=11 each, P<0.05; norepinephrine: 1359+/-159 vs 656+/-88 pg. ml(-1), n=9 each, P<0.001). Sympathetic activation may enhance the expression of Na+-Ca2+ exchanger in end-stage heart failure. The data support the hypothesis that increased Na+-Ca2+-exchange could favour malignant ventricular arrhythmias. Aims In end-stage heart failure, an alteration in the expression of the Na+-Ca2+ exchanger has been reported. Regulation of its expression is largely unknown. We sought to find out whether Na+-Ca2+ exchanger in human heart failure is regulated by sympathetic activation. In addition, since Na+-Ca2+-exchange is electrogenic, we conjectured whether increased expression of Na+-Ca2+ exchanger is associated with an increased incidence of cardiac arrhythmias. Methods and Results Twenty-three patients suffering from end-stage cardiac failure were examined in the hours preceding cardiac transplantation. Plasma levels of norepinephrine, epinephrine, atrial natriuretic peptide, renin activity, aldosterone, tumour necrosis factor (TNF)-α, and TNF-receptors were measured. All parameters were elevated relative to 21 healthy control subjects. As determined by immunoblots, protein levels of the Na+-Ca2+ exchanger were increased by 56% and protein levels of sarcoplasmic reticulum (SR) Ca2+-ATPase were decreased by 20% in left ventricles of the explanted failing hearts. A significant correlation between protein and neurohumoral levels was exclusively found for the Na+-Ca2+ exchanger with norepinephrine (r=0·64;P =0·01). Recent Holter ECGs revealed that patients with sustained or non-sustained ventricular tachycardia (more than three consecutive beats) had significantly higher Na+-Ca2+ exchanger protein and plasma norepinephrine levels than patients with a maximum of two consecutive beats (Na+-Ca2+ exchanger: 109±10 vs 83±7, n=11 each, P<0·05; norepinephrine: 1359±159 vs 656±88pg.ml−1, n=9 each, P<0·001). Conclusions Sympathetic activation may enhance the expression of Na+-Ca2+ exchanger in end-stage heart failure. The data support the hypothesis that increased Na+-Ca2+-exchange could favour malignant ventricular arrhythmias. Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved. |
Author | Minami, K. Schillinger, W. Hasenfuss, G. Ferrari, R. Schneider, H. |
Author_xml | – sequence: 1 givenname: W. surname: Schillinger fullname: Schillinger, W. organization: Zentrum Innere Medizin, Abt. Kardiologie und Pneumologie, Universität Göttingen, Germany – sequence: 2 givenname: H. surname: Schneider fullname: Schneider, H. organization: Innere Medizin/Endokrinologie und klinische Chemie, Max-Planck-Institut für Psychiatrie, München, Germany – sequence: 3 givenname: K. surname: Minami fullname: Minami, K. organization: Klinik für Thorax- und Kardiovascularchirurgie, Herzzentrum Nordrhein-Westfalen, Bad Oeynhausen, Germany – sequence: 4 givenname: R. surname: Ferrari fullname: Ferrari, R. organization: Centro di Fisiopatologia Cardiovascolare, Università di Ferrara, Gussago, Brescia, Italy – sequence: 5 givenname: G. surname: Hasenfuss fullname: Hasenfuss, G. organization: Zentrum Innere Medizin, Abt. Kardiologie und Pneumologie, Universität Göttingen, Germany |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13783770$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/12090750$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kU1v1DAURS1U1E5LtyyRN7CpMthxEttLNNAPUQGLtqrYWC-OPeOSOKntoM6_J2EGKiGxsnR17rN07jE68L03CL2mZElJyd6bcfOwzAmhS0aK4gVa0DLPM1kV5QFaECrLrKrE_RE6jvGBECIqWh2iI5oTSXhJFihedUMfEnhtcG9x3HYDpI1JTmPQyf2E5HqPbR_wlGLzNAQT4xxN8Bc4y1aQn02x3oBfm4Cdx8Y3WUywNtiCa51f483YgcfdttcQGjd2r9BLC200p_v3BN2ef7pZXWbXXy-uVh-uM80YTVnFWVNYAazWwjYFs40lUpNcA-GypsLYshZU25xVvCmN5FBLKSRooQ23TcVO0Lvd3SH0j6OJSXUuatO24E0_RsWpqDjJ6QS-2YNj3ZlGDcF1ELbqj6YJeLsHIGpobZh8ufjMMS4Y5zO33HE69DEGY58Roua91LyXmvdS815TofinoF367TyFyd7_a9mu5mIyT38_gfBDTdZ4qS7vv6uPxTdZfL67UZz9AqCoqlw |
CitedBy_id | crossref_primary_10_1016_j_ejheart_2006_10_014 crossref_primary_10_1152_physrev_00014_2006 crossref_primary_10_1517_13543784_13_6_653 crossref_primary_10_1113_jphysiol_2010_203398 crossref_primary_10_1016_j_ejheart_2007_01_011 crossref_primary_10_1161_01_RES_0000069701_19660_14 crossref_primary_10_1161_JAHA_117_005869 crossref_primary_10_1016_j_jsha_2012_01_004 crossref_primary_10_1152_ajpheart_01304_2004 crossref_primary_10_1007_BF02254368 crossref_primary_10_1161_JAHA_120_016900 crossref_primary_10_1016_j_aquatox_2013_07_014 crossref_primary_10_1161_CIRCULATIONAHA_104_494476 crossref_primary_10_1006_jmcc_2002_2037 crossref_primary_10_1007_s10741_019_09883_1 crossref_primary_10_3390_ijms242015472 crossref_primary_10_1007_s10646_013_1107_4 crossref_primary_10_1016_j_cardfail_2008_07_232 crossref_primary_10_1152_ajpheart_00534_2009 |
ContentType | Journal Article |
Copyright | 2002 INIST-CNRS Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved. |
Copyright_xml | – notice: 2002 INIST-CNRS – notice: Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved. |
DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1053/euhj.2001.3044 |
DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1522-9645 |
EndPage | 1124 |
ExternalDocumentID | 12090750 13783770 10_1053_euhj_2001_3044 ark_67375_HXZ_D4P94KVT_7 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K -E4 .2P .GJ .I3 .ZR 0R~ 18M 1B1 1TH 2WC 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 70D AABZA AACZT AAFWJ AAJKP AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABNGD ABNHQ ABNKS ABOCM ABPQP ABPTD ABQLI ABQNK ABVGC ABWST ABXVV ABZBJ ACGFO ACGFS ACPRK ACUFI ACUKT ACUTO ACYHN ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADNBA ADOCK ADQBN ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEWNT AFFNX AFFZL AFIYH AFOFC AFXAL AFYAG AGINJ AGKEF AGORE AGQPQ AGQXC AGSYK AGUTN AHMBA AHMMS AHXPO AIAGR AIJHB AJBYB AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APWMN ASPBG ATGXG AVWKF AXUDD AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BSCLL BTRTY BVRKM C1A CAG CDBKE COF CS3 CZ4 DAKXR DIK DILTD D~K E3Z EBS EE~ EJD EMOBN ENERS F5P F9B FECEO FEDTE FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H5~ HAR HVGLF HW0 HZ~ IHE IOX J21 JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B M-Z M41 MHKGH ML0 N4W N9A NGC NOMLY NOYVH NU- NVLIB O0~ O9- OAUYM OAWHX OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OWPYF P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y R44 RD5 ROL ROX ROZ RPZ RUSNO RW1 RXO SEL TCURE TEORI TJX UHS W8F WOQ X7H YAYTL YKOAZ YXANX ZGI ZKX ~91 AAYXX CITATION .XZ 08P 29G AAJQQ AAPGJ AAWDT ABSMQ ACFRR ACPQN ACUTJ ACVCV ACZBC ADGHP ADMTO AEHUL AEKPW AFFQV AFSHK AGKRT AGMDO AHGBF AI. AJDVS APJGH AQDSO AQKUS ATTQO AVNTJ BCGUY BZKNY C45 EIHJH H13 IQODW MBLQV NQ- NTWIH OB3 OBFPC OGROG OVD O~Y QBD RIG RNI RZF TMA VH1 6.Y ABQTQ ABSAR ADJQC ADRIX AFXEN CGR CUY CVF ECM EIF M49 NPM 7X8 |
ID | FETCH-LOGICAL-c331t-673d4f8a3bc8fd43fdf09c02ca079b18ef5b81cf2367d5e97ab9989ac8ce7fd63 |
ISSN | 0195-668X |
IngestDate | Fri Jul 11 15:43:02 EDT 2025 Wed Feb 19 02:35:35 EST 2025 Mon Jul 21 09:14:40 EDT 2025 Tue Jul 01 02:47:56 EDT 2025 Thu Apr 24 23:00:29 EDT 2025 Tue Aug 05 16:50:21 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 14 |
Keywords | Human Heart failure Calcium ion Pathogenesis Heart disease Sodium ion Cardiovascular disease Ion exchanger Terminal stage Catecholamine Sympathetic nervous system |
Language | English |
License | CC BY 4.0 Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c331t-673d4f8a3bc8fd43fdf09c02ca079b18ef5b81cf2367d5e97ab9989ac8ce7fd63 |
Notes | ark:/67375/HXZ-D4P94KVT-7 local:0.1930441.1118 istex:499958B751A54780B8443FEAA94B79932BDE2F0B ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://academic.oup.com/eurheartj/article-pdf/23/14/1118/17885047/1118.pdf |
PMID | 12090750 |
PQID | 71867021 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_71867021 pubmed_primary_12090750 pascalfrancis_primary_13783770 crossref_primary_10_1053_euhj_2001_3044 crossref_citationtrail_10_1053_euhj_2001_3044 istex_primary_ark_67375_HXZ_D4P94KVT_7 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2002-07-01 |
PublicationDateYYYYMMDD | 2002-07-01 |
PublicationDate_xml | – month: 07 year: 2002 text: 2002-07-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Oxford |
PublicationPlace_xml | – name: Oxford – name: England |
PublicationTitle | European heart journal |
PublicationTitleAlternate | Eur Heart J |
PublicationYear | 2002 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | 12090743 - Eur Heart J. 2002 Jul;23(14):1078-80 |
References_xml | – reference: 12090743 - Eur Heart J. 2002 Jul;23(14):1078-80 |
SSID | ssj0008616 |
Score | 1.8282357 |
Snippet | Aims In end-stage heart failure, an alteration in the expression of the Na+-Ca2+ exchanger has been reported. Regulation of its expression is largely unknown.... In end-stage heart failure, an alteration in the expression of the Na+-Ca2+ exchanger has been reported. Regulation of its expression is largely unknown. We... |
SourceID | proquest pubmed pascalfrancis crossref istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1118 |
SubjectTerms | Arrhythmia Biological and medical sciences Biological Transport calcium Cardiac Catheterization Cardiology. Vascular system Case-Control Studies catecholamines Catecholamines - analysis Catecholamines - biosynthesis Cohort Studies Electrocardiography, Ambulatory Female Heart heart failure Heart Failure - diagnosis Heart Failure - enzymology Heart Failure - surgery Heart failure, cardiogenic pulmonary edema, cardiac enlargement Heart Transplantation Humans Male Medical sciences Middle Aged myocardium Myocardium - enzymology Na+-Ca2+-exchanger Preoperative Care Probability Reference Values Severity of Illness Index Sodium-Potassium-Exchanging ATPase - analysis Sodium-Potassium-Exchanging ATPase - metabolism Sympathetic Nervous System - physiology |
Title | Importance of sympathetic activation for the expression of Na+-Ca2+ exchanger in end-stage failing human myocardium |
URI | https://api.istex.fr/ark:/67375/HXZ-D4P94KVT-7/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/12090750 https://www.proquest.com/docview/71867021 |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELZCKyEuiHfDo_iA4BBt2feujyFNSUCJUJRCxGVle20okA1qNlLLL-HnMuN9pmp5XTaR4zirfJ_t8ezMfIQ8A5M2CFyhrcjTnuUrO7UEZ46lGY-ZcoQvFeYOT6bh6Nh_swgWnc7PVtTSJhcH8seleSX_gyq0Aa6YJfsPyNaDQgO8B3zhCgjD9a8wHi-N9YxzE2y-9fkS9YWVKcEqK9myOo5QnZUxr8ZAnILR-MoacBde4KMq_xcLiGSpBSbjJ9XT_MQkqxc6fstz2PaATmXthovefFTGznvt20a_zWCE3oIq3uJDq306HB8WrfXDqsl42p-Mt3yvR8PZrD8bN5GNlYOiCWbNf5f42PZpssAKQ6MwXC_KRRJyRT6_tcTC4hy3tmuwF_1LtwLb6Hmozecv6AVwDjy7KDS5XXP7wl5YRyg6XgRH98i-RnZdOICgNsbrRRM8FIdGVLe-9aocaOC93P7FLXNnF2fuGYbf8jXMQF1Ip1x9tjE2zvwWuVkeTmi_YNpt0lHZHXJ9UoZf3CXrhnB0pWmLcLQhHAUgKLTShnDYecp7SLcerclGTzJak42WZKOGbLQh2z1yfDScD0ZWqdphSc9zcswlSX0dc0_IWKe-p1NtM2m7ktsRE06sdCBiR2osHZgGikVcwJGfcRlLFek09O6TnWyVqT1C08gJQqF4nDLhu9LmmvOQhYrDGRlokHaJVf25iSxL2qOyyrfEhFYEXoJgoNKqkyAYXfKi7v-9KOZyZc_nBqu6Gz_9iiGQUZCMFh-TQ_8d89--nydRl-xvgdmMWxKoS55W6CawcuPjOJ6p1WadRFhLEkzsLnlQgN5817UZmvIP_zT4I3KjmXGPyU5-ulFPwEjOxb7h6y_5y75H |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Importance+of+sympathetic+activation+for+the+expression+of+Na%2B-Ca2%2B+exchanger+in+end-stage+failing+human+myocardium&rft.jtitle=European+heart+journal&rft.au=SCHILLINGER%2C+W&rft.au=SCHNEIDER%2C+H&rft.au=MINAMI%2C+K&rft.au=FERRARI%2C+R&rft.date=2002-07-01&rft.pub=Oxford+University+Press&rft.issn=0195-668X&rft.volume=23&rft.issue=14&rft.spage=1118&rft.epage=1124&rft_id=info:doi/10.1053%2Feuhj.2001.3044&rft.externalDBID=n%2Fa&rft.externalDocID=13783770 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0195-668X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0195-668X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0195-668X&client=summon |